Fem Prenatal
Natural health product licensed in Canada
- Licence holder
- Metagenics Inc.
- NPN or DIN-HM
- 80050697
- Status
- Active licence
- Licence date
- 8 May 2014
- Revision date
- 8 September 2014
- Form
- Kit
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Cuivre Source : Citrate cuivrique | 1,000 mcg | Not calculated |
| Zinc Source : Citrate de zinc | 12.5 mg | Not calculated |
| Magnésium Source : Aspartate de magnésium | 62.5 mg | Not calculated |
| Magnésium Source : Citrate de magnésium | 62.5 mg | Not calculated |
| Thiamine Source : Mononitrate de thiamine | 1.7 mg | Not calculated |
| Acide d-pantothénique Source : D-Pantothénate de calcium | 10 mg | Not calculated |
| Sélénium Source : Produit de chélation de sélénium et de protéine végétale hydrolysée (PVH) | 37.5 mcg | Not calculated |
| Vitamine A Source : Palmitate de vitamine A | 225 mcg EAR | Not calculated |
| Calcium Source : Citrate de calcium | 125 mg | Not calculated |
| Vitamine D Source : Cholécalciférol | 2.5 mcg | Not calculated |
| Vitamine E Source : Succinate d'acide de dl-alpha tocophéryle | 30.15 mg AT | Not calculated |
| Biotine Source : Biotine | 150 mcg | Not calculated |
| 1,2,3,5/4,6- hexahydroxycyclohexane Source : Inositol | 25 mg | Not calculated |
| Vitamin K1 Source : Vitamine K1 | 32.5 mcg | Not calculated |
Non-medicinal ingredients
Hypromellose, triglycérides à chaînes moyennes, Dioxyde de silicium, Acide stéarique, Croscarmellose de sodium, Hydroxypropylcellulose, chlorophylline de cuivre sodium, cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe féminin | Not specified | 1 packet | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce the risk of neural tube defects when taken daily prior to becoming pregnant and during early pregnancy. A factor for the maintenance of good health. Helps in the development and maintenance of bones and teeth. Helps to maintain immune function. Helps pregnant women meet the recommended intake for iron. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80050697
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed. Photograph the packaging